Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

ISPE elects representatives to its 2012–2013 International Board of Directors ISPE elects representatives to its 2012–2013 International Board of Directors Names officers, pre-elected directors and new directors Gerresheimer appoints chief financial officer Gerresheimer appoints chief financial officer Rainer Beaujean takes up the role in February 2013 Flemming Ornskov to become Shire CEO Flemming Ornskov to become Shire CEO Following the retirement of Angus Russell ArGEN-X appoints David Lacey to supervisory board ArGEN-X appoints David Lacey to supervisory board Former head of discovery research at Amgen joins the Dutch firm L’Oréal-UNESCO honours five Women in Science L’Oréal-UNESCO honours five Women in Science In the 2013 For Women in Science Awards Rainer-Rudolph-Foundation acknowledges outstanding research Rainer-Rudolph-Foundation acknowledges outstanding research Awards three prizes to young researchers in the fields of protein biochemistry and biotechnology Azelis gears up for growth Azelis gears up for growth Makes two key appointments Evonik opens up new world in chemistry education Evonik opens up new world in chemistry education Evonik opens up new world in chemistry education Sponsors the Cyber Classrooms programme in schools Freeman Technology makes senior appointment in Asia Pacific Freeman Technology makes senior appointment in Asia Pacific Freeman Technology makes senior appointment in Asia Pacific And extends distribution agreement with DKSH Vaxxas appoints David Hoey as chief executive Vaxxas appoints David Hoey as chief executive Establishes operations in Boston, Massachusetts, US to expand access to global partners Christopher Tovey joins GW Pharmaceuticals Christopher Tovey joins GW Pharmaceuticals Christopher Tovey joins GW Pharmaceuticals As chief operating officer Sanofi promotes Dr Paul Chew Sanofi promotes Dr Paul Chew Sanofi promotes Dr Paul Chew To svp, chief medical officer and head of global affairs Mucosis promotes Thomas Johnston to ceo Mucosis promotes Thomas Johnston to ceo He joined the Dutch vaccine developer from Novavax in 2011 Dr Brett Haumann joins Circassia as chief medical officer Dr Brett Haumann joins Circassia as chief medical officer Stewart Sharpe takes newly created role of vp, commercial operations Capsugel makes key appointments to drive operational excellence Capsugel makes key appointments to drive operational excellence Seven executives join the firm to lead all major departments MP Keith Vaz visits Quotient Diagnostics MP Keith Vaz visits Quotient Diagnostics MP Keith Vaz visits Quotient Diagnostics To collect a donation of blood analysers for the Silver Star charity
  • Previous
  • 1
  • …
  • 152
  • 153
  • 154
  • 155 (current)
  • 156
  • 157
  • 158
  • …
  • 216
  • Next

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK. Terms and Conditions | Privacy